Rob Hopfner is a Managing Director at Pivotal Life Sciences and Managing Partner at Pivotal bioVenture Partners. He has experience in venture investing and pharmaceutical business development.
One email when Rob's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckRob Hopfner is a Managing Director at Pivotal Life Sciences and Managing Partner at Pivotal bioVenture Partners. He has experience in venture investing and pharmaceutical business development.
Pivotal Life Sciences has not reported a check size.
A warm intro from a founder Pivotal Life Sciences backed works best.
DuPont / Merck Pharmaceuticals; Managing Director at Bay City Capital; Managing Partner at Pivotal bioVenture Partners (US).
Last updated 2026-10-15. Is this you? Ask for a correction.